Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.
Identifieur interne : 000271 ( Main/Exploration ); précédent : 000270; suivant : 000272Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.
Auteurs : Diego Viasus [Espagne] ; Carmen Marinescu ; Aroa Villoslada ; Elisa Cordero ; Juan Gálvez-Acebal ; María C. Fari As ; Irene Gracia-Ahufinger ; Anabel Fernández-Navarro ; Jordi Niub ; Lucia Ortega ; Elena Mu Ez-Rubio ; María P. Romero-G Mez ; Jordi CarratalàSource :
- The Journal of infection [ 1532-2742 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse multifactorielle (MeSH), Centres de soins tertiaires (statistiques et données numériques), Courbe ROC (MeSH), Espagne (épidémiologie), Facteurs de risque (MeSH), Femelle (MeSH), Grippe humaine (microbiologie), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Infections communautaires (microbiologie), Infections communautaires (virologie), Infections communautaires (épidémiologie), Liquide de lavage bronchoalvéolaire (microbiologie), Liquide de lavage bronchoalvéolaire (virologie), Mâle (MeSH), Partie nasale du pharynx (microbiologie), Partie nasale du pharynx (virologie), Pneumopathie infectieuse (microbiologie), Pneumopathie infectieuse (virologie), Pneumopathie infectieuse (épidémiologie), Résultat thérapeutique (MeSH), Sous-type H1N1 du virus de la grippe A (isolement et purification), Sujet âgé (MeSH), Études prospectives (MeSH).
- MESH :
- isolement et purification : Sous-type H1N1 du virus de la grippe A.
- microbiologie : Grippe humaine, Infections communautaires, Liquide de lavage bronchoalvéolaire, Partie nasale du pharynx, Pneumopathie infectieuse.
- statistiques et données numériques : Centres de soins tertiaires.
- virologie : Grippe humaine, Infections communautaires, Liquide de lavage bronchoalvéolaire, Partie nasale du pharynx, Pneumopathie infectieuse.
- épidémiologie : Espagne, Grippe humaine, Infections communautaires, Pneumopathie infectieuse.
- Adulte, Adulte d'âge moyen, Analyse multifactorielle, Courbe ROC, Facteurs de risque, Femelle, Humains, Mâle, Résultat thérapeutique, Sujet âgé, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Bronchoalveolar Lavage Fluid (microbiology), Bronchoalveolar Lavage Fluid (virology), Community-Acquired Infections (epidemiology), Community-Acquired Infections (microbiology), Community-Acquired Infections (virology), Female (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza, Human (epidemiology), Influenza, Human (microbiology), Influenza, Human (virology), Male (MeSH), Middle Aged (MeSH), Multivariate Analysis (MeSH), Nasopharynx (microbiology), Nasopharynx (virology), Pneumonia (epidemiology), Pneumonia (microbiology), Pneumonia (virology), Prospective Studies (MeSH), ROC Curve (MeSH), Risk Factors (MeSH), Spain (epidemiology), Tertiary Care Centers (statistics & numerical data), Treatment Outcome (MeSH).
- MESH :
- geographic , epidemiology : Spain.
- epidemiology : Community-Acquired Infections, Influenza, Human, Pneumonia.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- microbiology : Bronchoalveolar Lavage Fluid, Community-Acquired Infections, Influenza, Human, Nasopharynx, Pneumonia.
- statistics & numerical data : Tertiary Care Centers.
- virology : Bronchoalveolar Lavage Fluid, Community-Acquired Infections, Influenza, Human, Nasopharynx, Pneumonia.
- Adult, Aged, Female, Humans, Male, Middle Aged, Multivariate Analysis, Prospective Studies, ROC Curve, Risk Factors, Treatment Outcome.
Abstract
OBJECTIVES
To determine the aetiology, clinical features and prognosis of CAP during the first post-pandemic influenza season. We also assessed the factors associated with severe disease and tested the ability of a scoring system for identifying influenza A (H1N1)pdm09-related pneumonia.
METHODS
Prospective cohort study carried out at 10 tertiary hospitals of Spain. All adults hospitalised with CAP from December 01, 2010 to March 31, 2011 were analysed.
RESULTS
A total of 747 adults with CAP required hospitalisation. The aetiology was determined in 315 (42.2%) patients, in whom 154 (21.9%) were due to bacteria, 125 (16.7%) were due to viruses and 36 (4.8%) were mixed (due to viruses and bacteria). The most frequently isolated bacteria were Streptococccus pneumoniae. Among patients with viral pneumonia, the most common organism identified were influenza A (H1N1)pdm09. Independent factors associated with severe disease were impaired consciousness, septic shock, tachypnea, hyponatremia, hypoxemia, influenza B, and influenza A (H1N1)pdm09. The scoring system evaluated did not differentiate reliably between patients with influenza A (H1N1)pdm09-related pneumonia and those with other aetiologies.
CONCLUSIONS
The frequency of bacterial and viral pneumonia during the first post-pandemic influenza season was similar. The main identified virus was influenza A (H1N1)pdm09, which was associated with severe disease. Although certain presenting clinical features may allow recognition of influenza A (H1N1)pdm09-related pneumonia, it is difficult to express them in a reliable scoring system.
DOI: 10.1016/j.jinf.2013.05.006
PubMed: 23747416
PubMed Central: PMC7112525
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.</title>
<author><name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
<affiliation wicri:level="2"><nlm:affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Feixa Llarga s/n, 08907 Barcelona, Spain. dfviasusp@gmail.com</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Feixa Llarga s/n, 08907 Barcelona</wicri:regionArea>
<placeName><region nuts="2" type="communauté">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marinescu, Carmen" sort="Marinescu, Carmen" uniqKey="Marinescu C" first="Carmen" last="Marinescu">Carmen Marinescu</name>
</author>
<author><name sortKey="Villoslada, Aroa" sort="Villoslada, Aroa" uniqKey="Villoslada A" first="Aroa" last="Villoslada">Aroa Villoslada</name>
</author>
<author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
</author>
<author><name sortKey="Galvez Acebal, Juan" sort="Galvez Acebal, Juan" uniqKey="Galvez Acebal J" first="Juan" last="Gálvez-Acebal">Juan Gálvez-Acebal</name>
</author>
<author><name sortKey="Fari As, Maria C" sort="Fari As, Maria C" uniqKey="Fari As M" first="María C" last="Fari As">María C. Fari As</name>
</author>
<author><name sortKey="Gracia Ahufinger, Irene" sort="Gracia Ahufinger, Irene" uniqKey="Gracia Ahufinger I" first="Irene" last="Gracia-Ahufinger">Irene Gracia-Ahufinger</name>
</author>
<author><name sortKey="Fernandez Navarro, Anabel" sort="Fernandez Navarro, Anabel" uniqKey="Fernandez Navarro A" first="Anabel" last="Fernández-Navarro">Anabel Fernández-Navarro</name>
</author>
<author><name sortKey="Niub, Jordi" sort="Niub, Jordi" uniqKey="Niub J" first="Jordi" last="Niub">Jordi Niub</name>
</author>
<author><name sortKey="Ortega, Lucia" sort="Ortega, Lucia" uniqKey="Ortega L" first="Lucia" last="Ortega">Lucia Ortega</name>
</author>
<author><name sortKey="Mu Ez Rubio, Elena" sort="Mu Ez Rubio, Elena" uniqKey="Mu Ez Rubio E" first="Elena" last="Mu Ez-Rubio">Elena Mu Ez-Rubio</name>
</author>
<author><name sortKey="Romero G Mez, Maria P" sort="Romero G Mez, Maria P" uniqKey="Romero G Mez M" first="María P" last="Romero-G Mez">María P. Romero-G Mez</name>
</author>
<author><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23747416</idno>
<idno type="pmid">23747416</idno>
<idno type="doi">10.1016/j.jinf.2013.05.006</idno>
<idno type="pmc">PMC7112525</idno>
<idno type="wicri:Area/Main/Corpus">00240</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00240</idno>
<idno type="wicri:Area/Main/Curation">000240</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000240</idno>
<idno type="wicri:Area/Main/Exploration">000240</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.</title>
<author><name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
<affiliation wicri:level="2"><nlm:affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Feixa Llarga s/n, 08907 Barcelona, Spain. dfviasusp@gmail.com</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Feixa Llarga s/n, 08907 Barcelona</wicri:regionArea>
<placeName><region nuts="2" type="communauté">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marinescu, Carmen" sort="Marinescu, Carmen" uniqKey="Marinescu C" first="Carmen" last="Marinescu">Carmen Marinescu</name>
</author>
<author><name sortKey="Villoslada, Aroa" sort="Villoslada, Aroa" uniqKey="Villoslada A" first="Aroa" last="Villoslada">Aroa Villoslada</name>
</author>
<author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
</author>
<author><name sortKey="Galvez Acebal, Juan" sort="Galvez Acebal, Juan" uniqKey="Galvez Acebal J" first="Juan" last="Gálvez-Acebal">Juan Gálvez-Acebal</name>
</author>
<author><name sortKey="Fari As, Maria C" sort="Fari As, Maria C" uniqKey="Fari As M" first="María C" last="Fari As">María C. Fari As</name>
</author>
<author><name sortKey="Gracia Ahufinger, Irene" sort="Gracia Ahufinger, Irene" uniqKey="Gracia Ahufinger I" first="Irene" last="Gracia-Ahufinger">Irene Gracia-Ahufinger</name>
</author>
<author><name sortKey="Fernandez Navarro, Anabel" sort="Fernandez Navarro, Anabel" uniqKey="Fernandez Navarro A" first="Anabel" last="Fernández-Navarro">Anabel Fernández-Navarro</name>
</author>
<author><name sortKey="Niub, Jordi" sort="Niub, Jordi" uniqKey="Niub J" first="Jordi" last="Niub">Jordi Niub</name>
</author>
<author><name sortKey="Ortega, Lucia" sort="Ortega, Lucia" uniqKey="Ortega L" first="Lucia" last="Ortega">Lucia Ortega</name>
</author>
<author><name sortKey="Mu Ez Rubio, Elena" sort="Mu Ez Rubio, Elena" uniqKey="Mu Ez Rubio E" first="Elena" last="Mu Ez-Rubio">Elena Mu Ez-Rubio</name>
</author>
<author><name sortKey="Romero G Mez, Maria P" sort="Romero G Mez, Maria P" uniqKey="Romero G Mez M" first="María P" last="Romero-G Mez">María P. Romero-G Mez</name>
</author>
<author><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
</author>
</analytic>
<series><title level="j">The Journal of infection</title>
<idno type="eISSN">1532-2742</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Bronchoalveolar Lavage Fluid (microbiology)</term>
<term>Bronchoalveolar Lavage Fluid (virology)</term>
<term>Community-Acquired Infections (epidemiology)</term>
<term>Community-Acquired Infections (microbiology)</term>
<term>Community-Acquired Infections (virology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (microbiology)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Multivariate Analysis (MeSH)</term>
<term>Nasopharynx (microbiology)</term>
<term>Nasopharynx (virology)</term>
<term>Pneumonia (epidemiology)</term>
<term>Pneumonia (microbiology)</term>
<term>Pneumonia (virology)</term>
<term>Prospective Studies (MeSH)</term>
<term>ROC Curve (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Tertiary Care Centers (statistics & numerical data)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Analyse multifactorielle (MeSH)</term>
<term>Centres de soins tertiaires (statistiques et données numériques)</term>
<term>Courbe ROC (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (microbiologie)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Infections communautaires (microbiologie)</term>
<term>Infections communautaires (virologie)</term>
<term>Infections communautaires (épidémiologie)</term>
<term>Liquide de lavage bronchoalvéolaire (microbiologie)</term>
<term>Liquide de lavage bronchoalvéolaire (virologie)</term>
<term>Mâle (MeSH)</term>
<term>Partie nasale du pharynx (microbiologie)</term>
<term>Partie nasale du pharynx (virologie)</term>
<term>Pneumopathie infectieuse (microbiologie)</term>
<term>Pneumopathie infectieuse (virologie)</term>
<term>Pneumopathie infectieuse (épidémiologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Sujet âgé (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Community-Acquired Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Infections communautaires</term>
<term>Liquide de lavage bronchoalvéolaire</term>
<term>Partie nasale du pharynx</term>
<term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Bronchoalveolar Lavage Fluid</term>
<term>Community-Acquired Infections</term>
<term>Influenza, Human</term>
<term>Nasopharynx</term>
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Tertiary Care Centers</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Centres de soins tertiaires</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Infections communautaires</term>
<term>Liquide de lavage bronchoalvéolaire</term>
<term>Partie nasale du pharynx</term>
<term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Bronchoalveolar Lavage Fluid</term>
<term>Community-Acquired Infections</term>
<term>Influenza, Human</term>
<term>Nasopharynx</term>
<term>Pneumonia</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
<term>Infections communautaires</term>
<term>Pneumopathie infectieuse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multivariate Analysis</term>
<term>Prospective Studies</term>
<term>ROC Curve</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse multifactorielle</term>
<term>Courbe ROC</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>To determine the aetiology, clinical features and prognosis of CAP during the first post-pandemic influenza season. We also assessed the factors associated with severe disease and tested the ability of a scoring system for identifying influenza A (H1N1)pdm09-related pneumonia.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Prospective cohort study carried out at 10 tertiary hospitals of Spain. All adults hospitalised with CAP from December 01, 2010 to March 31, 2011 were analysed.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>A total of 747 adults with CAP required hospitalisation. The aetiology was determined in 315 (42.2%) patients, in whom 154 (21.9%) were due to bacteria, 125 (16.7%) were due to viruses and 36 (4.8%) were mixed (due to viruses and bacteria). The most frequently isolated bacteria were Streptococccus pneumoniae. Among patients with viral pneumonia, the most common organism identified were influenza A (H1N1)pdm09. Independent factors associated with severe disease were impaired consciousness, septic shock, tachypnea, hyponatremia, hypoxemia, influenza B, and influenza A (H1N1)pdm09. The scoring system evaluated did not differentiate reliably between patients with influenza A (H1N1)pdm09-related pneumonia and those with other aetiologies.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The frequency of bacterial and viral pneumonia during the first post-pandemic influenza season was similar. The main identified virus was influenza A (H1N1)pdm09, which was associated with severe disease. Although certain presenting clinical features may allow recognition of influenza A (H1N1)pdm09-related pneumonia, it is difficult to express them in a reliable scoring system.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23747416</PMID>
<DateCompleted><Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>67</Volume>
<Issue>3</Issue>
<PubDate><Year>2013</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of infection</Title>
<ISOAbbreviation>J. Infect.</ISOAbbreviation>
</Journal>
<ArticleTitle>Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.</ArticleTitle>
<Pagination><MedlinePgn>185-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2013.05.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0163-4453(13)00131-X</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the aetiology, clinical features and prognosis of CAP during the first post-pandemic influenza season. We also assessed the factors associated with severe disease and tested the ability of a scoring system for identifying influenza A (H1N1)pdm09-related pneumonia.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Prospective cohort study carried out at 10 tertiary hospitals of Spain. All adults hospitalised with CAP from December 01, 2010 to March 31, 2011 were analysed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 747 adults with CAP required hospitalisation. The aetiology was determined in 315 (42.2%) patients, in whom 154 (21.9%) were due to bacteria, 125 (16.7%) were due to viruses and 36 (4.8%) were mixed (due to viruses and bacteria). The most frequently isolated bacteria were Streptococccus pneumoniae. Among patients with viral pneumonia, the most common organism identified were influenza A (H1N1)pdm09. Independent factors associated with severe disease were impaired consciousness, septic shock, tachypnea, hyponatremia, hypoxemia, influenza B, and influenza A (H1N1)pdm09. The scoring system evaluated did not differentiate reliably between patients with influenza A (H1N1)pdm09-related pneumonia and those with other aetiologies.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The frequency of bacterial and viral pneumonia during the first post-pandemic influenza season was similar. The main identified virus was influenza A (H1N1)pdm09, which was associated with severe disease. Although certain presenting clinical features may allow recognition of influenza A (H1N1)pdm09-related pneumonia, it is difficult to express them in a reliable scoring system.</AbstractText>
<CopyrightInformation>Copyright © 2013 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viasus</LastName>
<ForeName>Diego</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Hospital Universitari de Bellvitge - IDIBELL, University of Barcelona, Feixa Llarga s/n, 08907 Barcelona, Spain. dfviasusp@gmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marinescu</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Villoslada</LastName>
<ForeName>Aroa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cordero</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gálvez-Acebal</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fariñas</LastName>
<ForeName>María C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gracia-Ahufinger</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fernández-Navarro</LastName>
<ForeName>Anabel</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Niubó</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ortega</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Muñez-Rubio</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Romero-Gómez</LastName>
<ForeName>María P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Carratalà</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>06</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Infect</MedlineTA>
<NlmUniqueID>7908424</NlmUniqueID>
<ISSNLinking>0163-4453</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical features</Keyword>
<Keyword MajorTopicYN="N">Community-acquired pneumonia</Keyword>
<Keyword MajorTopicYN="N">Influenza A (H1N1)pdm09</Keyword>
<Keyword MajorTopicYN="N">Mortality</Keyword>
<Keyword MajorTopicYN="N">Post-pandemic period</Keyword>
</KeywordList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Riera</LastName>
<ForeName>Melchor</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Payeras</LastName>
<ForeName>Antoni</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Férnandez-Baca</LastName>
<ForeName>Victoria</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gutiérrez</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aydillo</LastName>
<ForeName>Teresa</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sánchez</LastName>
<ForeName>Magdalena</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Osorio</LastName>
<ForeName>Giovana</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Milara</LastName>
<ForeName>Caridad</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Perez-Romero</LastName>
<ForeName>Pilar</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pachón</LastName>
<ForeName>Jerónimo</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fernández-Cuenca</LastName>
<ForeName>Felipe</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rodríguez-Baño</LastName>
<ForeName>Jesús</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ruiz</LastName>
<ForeName>Carmen Casillas</ForeName>
<Initials>CC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>de la Fuente</LastName>
<ForeName>Celia García</ForeName>
<Initials>CG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sanjuán</LastName>
<ForeName>María Victoria</ForeName>
<Initials>MV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Parra</LastName>
<ForeName>José Antonio</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Torre-Cisneros</LastName>
<ForeName>Julián</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Casal</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Causse</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gutiérrez-Aroca</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lara</LastName>
<ForeName>Rosario</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rivero</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rodríguez</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tejero</LastName>
<ForeName>Rocio</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Martínez-Montauti</LastName>
<ForeName>Joaquín</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Azorín</LastName>
<ForeName>Francisca Portero</ForeName>
<Initials>FP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Martínez</LastName>
<ForeName>Antonio Ramos</ForeName>
<Initials>AR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Montiel</LastName>
<ForeName>Teresa Álvarez-Espejo</ForeName>
<Initials>TÁ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Caro-Bragado</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Paño-Pardo</LastName>
<ForeName>José Ramón</ForeName>
<Initials>JR</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>02</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>05</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>6</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>5</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23747416</ArticleId>
<ArticleId IdType="pii">S0163-4453(13)00131-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.jinf.2013.05.006</ArticleId>
<ArticleId IdType="pmc">PMC7112525</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Microbiol Infect. 2012 Mar;18(3):E55-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22264321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 1999 Aug;160(2):397-405</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10430704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2012 Nov;65(5):423-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22820034</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17278083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2009;13(5):R148</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19747383</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chronic Dis. 1987;40(5):373-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(1):e30279</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22291929</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(4):e36120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22545158</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1935-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19815859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care Med. 2012 May;40(5):1487-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22511131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2011;15(6):R286</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22126648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2011 Jun 15;203(12):1739-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21606532</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2004 Dec;31(4):283-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15494270</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Jan 15;50(2):202-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20014950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 May;58(5):377-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12728155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2010 Mar;35(3):598-605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19679601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Medicine (Baltimore). 2011 Sep;90(5):328-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21862936</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2012 May;54(9):1221-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22437239</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2004 Mar;72(3):484-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14748074</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2009 Nov 4;302(17):1896-902</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19887665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2009 Nov 4;302(17):1872-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19822627</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cleve Clin J Med. 2012 Jan;79(1):67-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22219236</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2011 Apr 9;377(9773):1264-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21435708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2011 Nov 03;16(44):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22085621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2001 Jul 15;33(2):158-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11418874</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2011 May;17(5):738-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20825436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2011 Mar;66(3):247-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21252388</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
</list>
<tree><noCountry><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
<name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
<name sortKey="Fari As, Maria C" sort="Fari As, Maria C" uniqKey="Fari As M" first="María C" last="Fari As">María C. Fari As</name>
<name sortKey="Fernandez Navarro, Anabel" sort="Fernandez Navarro, Anabel" uniqKey="Fernandez Navarro A" first="Anabel" last="Fernández-Navarro">Anabel Fernández-Navarro</name>
<name sortKey="Galvez Acebal, Juan" sort="Galvez Acebal, Juan" uniqKey="Galvez Acebal J" first="Juan" last="Gálvez-Acebal">Juan Gálvez-Acebal</name>
<name sortKey="Gracia Ahufinger, Irene" sort="Gracia Ahufinger, Irene" uniqKey="Gracia Ahufinger I" first="Irene" last="Gracia-Ahufinger">Irene Gracia-Ahufinger</name>
<name sortKey="Marinescu, Carmen" sort="Marinescu, Carmen" uniqKey="Marinescu C" first="Carmen" last="Marinescu">Carmen Marinescu</name>
<name sortKey="Mu Ez Rubio, Elena" sort="Mu Ez Rubio, Elena" uniqKey="Mu Ez Rubio E" first="Elena" last="Mu Ez-Rubio">Elena Mu Ez-Rubio</name>
<name sortKey="Niub, Jordi" sort="Niub, Jordi" uniqKey="Niub J" first="Jordi" last="Niub">Jordi Niub</name>
<name sortKey="Ortega, Lucia" sort="Ortega, Lucia" uniqKey="Ortega L" first="Lucia" last="Ortega">Lucia Ortega</name>
<name sortKey="Romero G Mez, Maria P" sort="Romero G Mez, Maria P" uniqKey="Romero G Mez M" first="María P" last="Romero-G Mez">María P. Romero-G Mez</name>
<name sortKey="Villoslada, Aroa" sort="Villoslada, Aroa" uniqKey="Villoslada A" first="Aroa" last="Villoslada">Aroa Villoslada</name>
</noCountry>
<country name="Espagne"><region name="Catalogne"><name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000271 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000271 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:23747416 |texte= Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23747416" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |